These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 14241801)

  • 1. PRESERVATIVES FOR POLIOMYELITIS (SALK) VACCINE. 3. 2-PHENOXYETHANOL.
    PIVNICK H; TRACY JM; TOSONI AL; GLASS DG
    J Pharm Sci; 1964 Aug; 53():899-901. PubMed ID: 14241801
    [No Abstract]   [Full Text] [Related]  

  • 2. STUDIES OF PRESERVATIVES OF POLIOMYELITIS (SALK) VACCINE. I. BENZETHONIUM CHLORIDE.
    PIVNICK H; TRACY JM; GLASS DG
    J Pharm Sci; 1963 Sep; 52():883-8. PubMed ID: 14061050
    [No Abstract]   [Full Text] [Related]  

  • 3. PRESERVATIVES IN POLIOMYELITIS (SALK) VACCINE.
    TRACY J; PIVNICK H; GLASS DG
    Bull Parenter Drug Assoc; 1964; 18():6-24. PubMed ID: 14107092
    [No Abstract]   [Full Text] [Related]  

  • 4. PRESERVATIVES FOR POLIOMYELITIS (SALK) VACCINE. II. FORMALDEHYDE AND ESTERS OF P-HYDROXYBENZOIC ACID.
    TRACY JM; GLASS DG; NICHOLSON MJ; PIVNICK H
    J Pharm Sci; 1964 Jun; 53():659-63. PubMed ID: 14198442
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of 2-phenoxyethanol on potency of Sabin inactivated poliomyelitis vaccine and its safety].
    Bian CX; Jiang SD; Yang JY; Sun MB; Xie MX; Zhang XW; Liao GY; Li WD
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Mar; 21(1):44-6. PubMed ID: 17429533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [STUDIES ON TESTING THE SAFETY OF INACTIVATED POLIOMYELITIS VACCINES. II. SV 40 IN INACTIVATED POLIOMYELITIS VACCINES].
    GUENTHER O; HOEVEL H; VON METTENHEIM
    Zentralbl Bakteriol Orig; 1963 Dec; 190():445-65. PubMed ID: 14166424
    [No Abstract]   [Full Text] [Related]  

  • 7. [RESULTS WITH SALK TYPE POLIOMYELITIS VACCINE IN CORDOBA].
    GIMENODESANDE A
    Rev Sanid Hig Publica (Madr); 1965; 39():185-221. PubMed ID: 14307031
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of roosters in the antigenicity testing of Salk poliomyelitis vaccine.
    FURESZ J; MOREAU P
    J Immunol; 1963 Feb; 90():192-200. PubMed ID: 13945854
    [No Abstract]   [Full Text] [Related]  

  • 9. Poliomyelitis antibody levels of young children in Houston, 1961-62. Existence of susceptible pockets in an area using Salk vaccine of high effectiveness.
    ASHKENAZI AE; MELNICK JL
    Tex Rep Biol Med; 1962; 20():550-4. PubMed ID: 13965180
    [No Abstract]   [Full Text] [Related]  

  • 10. RESPONSE TO ONE DOSE OF TRIVALENT ORAL POLIOVACCINE IN CHILDREN PREVIOUSLY IMMUNISED WITH SALK VACCINE: A COMPARISON OF LIQUID VACCINE AND A CAPSULE PRESENTATION.
    BEALE AJ; DAVIES JR; THROWER AL
    Lancet; 1965 Apr; 1(7391):879-81. PubMed ID: 14272682
    [No Abstract]   [Full Text] [Related]  

  • 11. Review of the Louisiana State Board of Health experience with the use of Salk vaccine and comments on the Sabin oral polio vaccine.
    HEDMEG A
    J La State Med Soc; 1963 Feb; 115():41-7. PubMed ID: 13963684
    [No Abstract]   [Full Text] [Related]  

  • 12. A phase contrast microprecipitin test with poliovirus antigens. II. Occurrence and development of microprecipitin antibody after natural inapparent infections, after inoculation of Salk vaccine, after feeding of attenuated live poliovirus vaccine, and in disease caused by polioviruses and other enteroviruses.
    EGGERS HJ; SABIN AB
    Arch Gesamte Virusforsch; 1961; 11():152-75. PubMed ID: 13725917
    [No Abstract]   [Full Text] [Related]  

  • 13. [ON THE OCCURRENCE OF A POLIOMYELITIS OUTBREAK IN THE COMMUNE OF CARRARA AFTER THE VACCINATION CAMPAIGN OF 1958-1960 WITH SALK VACCINE].
    BARGHINI G; GALLO G
    Riv Ital Ig; 1964; 24():590-6. PubMed ID: 14337305
    [No Abstract]   [Full Text] [Related]  

  • 14. [STUDIES ON TESTS FOR THE NON-TOXICITY OF INACTIVATED POLIOMYELITIS VACCINES. 1. INFLUENCE OF MAGNESIUM CHLORIDE ON THE SUSCEPTIBILITY OF MONKEY KIDNEY CELL CULTURES TO FORMALIN-TREATED POLIOMYELITIS VIRUS].
    GUENTHER O; HOEVEL H; VON METTENHEIM
    Zentralbl Bakteriol Orig; 1963 Nov; 190():313-21. PubMed ID: 14105973
    [No Abstract]   [Full Text] [Related]  

  • 15. ANTIVIRAL AND ANTIBACTERIAL ACTIVITY OF THYMUS EXTRACTS.
    LI CP; PRESCOTT B; CHI LL; MARTINO EC
    Proc Soc Exp Biol Med; 1963 Nov; 114():504-9. PubMed ID: 14101224
    [No Abstract]   [Full Text] [Related]  

  • 16. THE PROTECTIVE EFFECT OF SALK VACCINE DURING AN EPIDEMIC OF POLIOMYELITIS, BRITISH COLUMBIA, 1959-1960.
    LARSEN AA
    Can J Public Health; 1965 Feb; 56():47-50. PubMed ID: 14281078
    [No Abstract]   [Full Text] [Related]  

  • 17. Some results of the work on mass immunization in the Soviet Union with live poliovirus vaccine prepared from Sabin strains.
    CHUMAKOV MP
    Bull World Health Organ; 1961; 25(1):79-91. PubMed ID: 13879389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A PLATE MICROMETHOD FOR DETERMINING THE FERMENTATIVE ABILITY OF PATHOGENIC BACTERIA.
    KOCWA E
    Arch Immunol Ther Exp (Warsz); 1964; 12():196-211. PubMed ID: 14166659
    [No Abstract]   [Full Text] [Related]  

  • 19. [RELATION BETWEEN CHEMICAL COMPOSITION AND ANTIMICROBIAL EFFECT. 8. BACTERIOSTATIC PROPERTIES OF SOME 8-HYDROXYQUINOLINE SALTS].
    WEUFFEN W; TARTLER G
    Pharmazie; 1963 Sep; 18():630-2. PubMed ID: 14204160
    [No Abstract]   [Full Text] [Related]  

  • 20. [STUDIES ON TESTING THE SAFETY OF INACTIVATED POLIOMYELITIS VACCINE. III. IS THERE INTERFERENCE BY SV 40 AGAINST POLIOVIRUS?].
    GUENTHER O; VON METTENHEIM ; HOEVEL H
    Zentralbl Bakteriol Orig; 1964 Feb; 192():1-11. PubMed ID: 14176847
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.